Z Zhu Selected Research

Therapeutics

2/2024	[Characteristics and clinical analysis of MLH1 c.463dupC gene mutation in a Lynch syndrome family].
10/2020	[Influence of different biological behaviors on prognosis of patients with advanced gastric cancer at the same TNM stage].
7/2020	[Advances in the research of clinical treatment of hyperpigmentation and hypopigmentation after burns].
9/2019	[Targeted therapy for malignant peripheral nerve sheath tumor: translational research and clinical application].
8/2015	Selection of a novel DNA thioaptamer against HER2 structure.
5/2014	Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysis.
3/2013	Transient receptor potential vanilloid 1 (TRPV1), TRPV4, and the kidney.
9/2001	Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
5/2001	[Influence of anisodamine on guinea pig experimental nasal hypersensitivity].
5/2001	Monoclonal antibody strategies to block angiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Z Zhu Research Topics

Disease

40	Neoplasms (Cancer) 10/2022 - 01/2000
15	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2000
14	Inflammation (Inflammations) 01/2023 - 11/2000
11	Asthma (Bronchial Asthma) 04/2013 - 02/2000
8	Pain (Aches) 01/2023 - 07/2003
8	Fibrosis (Cirrhosis) 05/2022 - 02/2000
6	Osteoarthritis 01/2023 - 01/2019
6	Knee Osteoarthritis 01/2021 - 01/2017
6	Carcinogenesis 01/2017 - 11/2000
6	Pancreatic Neoplasms (Pancreatic Cancer) 02/2013 - 02/2000
5	Type 2 Diabetes Mellitus (MODY) 07/2023 - 01/2012
5	Infections 08/2017 - 02/2000
5	Leukemia 08/2005 - 08/2000
4	Breast Neoplasms (Breast Cancer) 08/2021 - 08/2015
4	Lung Neoplasms (Lung Cancer) 10/2017 - 08/2006
4	Aplastic Anemia (Anemia, Hypoplastic) 11/2005 - 10/2000
4	Carcinoma (Carcinomatosis) 11/2001 - 02/2000
4	Chronic Pancreatitis 06/2001 - 02/2000
3	Adenocarcinoma 01/2023 - 07/2000
3	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 03/2016
3	Diabetes Mellitus 05/2022 - 01/2001
3	Synovitis 01/2022 - 01/2017
3	Burns 07/2020 - 12/2000
3	Stomach Neoplasms (Stomach Cancer) 12/2019 - 07/2010
3	Chronic Obstructive Pulmonary Disease (COPD) 05/2019 - 11/2000
3	Emphysema 05/2019 - 11/2000
3	Insulin Resistance 12/2017 - 01/2014
3	Prostatic Neoplasms (Prostate Cancer) 08/2016 - 11/2001
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2015 - 08/2005
3	Pneumonia (Pneumonitis) 03/2011 - 10/2005
3	Respiratory Hypersensitivity 10/2005 - 02/2000
3	Metaplasia 11/2001 - 11/2000
2	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 10/2015
2	Polyps 02/2024 - 08/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 01/2000
2	Hypersensitivity (Allergy) 09/2023 - 05/2001
2	Obesity 01/2023 - 01/2017
2	Myocardial Infarction 11/2022 - 06/2007
2	Hypertrophy 05/2022 - 08/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 04/2021 - 05/2018
2	Nasal Polyps (Nasal Polyp) 08/2020 - 08/2017
2	Esophageal Squamous Cell Carcinoma 07/2020 - 01/2020
2	Lymphatic Metastasis 01/2020 - 12/2019
2	Sepsis (Septicemia) 04/2017 - 06/2011
2	Diabetic Nephropathies (Diabetic Nephropathy) 06/2016 - 08/2013
2	Hemorrhage 06/2016 - 01/2001

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2000
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2003 - 05/2000
11	CytokinesIBA 08/2020 - 02/2000
8	AntibodiesIBA 12/2017 - 05/2000
7	Messenger RNA (mRNA)IBA 07/2010 - 02/2000
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2001
6	AllergensIBA 08/2017 - 06/2009
5	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2014
5	LigandsIBA 09/2019 - 07/2000
5	DNA (Deoxyribonucleic Acid)IBA 05/2015 - 11/2000
5	OvalbuminIBA 03/2011 - 10/2005
5	Interleukin-13IBA 11/2001 - 09/2000
4	Long Noncoding RNAIBA 10/2022 - 11/2013
4	CollagenIBA 05/2018 - 02/2000
4	AntigensIBA 12/2017 - 07/2001
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2003 - 08/2000
3	Vitamin D FDA LinkGeneric 01/2023 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022 - 01/2001
3	CateninsIBA 01/2022 - 08/2016
3	MicroRNAs (MicroRNA)IBA 09/2019 - 11/2013
3	Phosphotransferases (Kinase)IBA 09/2019 - 12/2000
3	Galectin 3 (LGALS3)IBA 01/2019 - 08/2000
3	Insulin (Novolin)FDA Link 12/2017 - 12/2000
3	RNA (Ribonucleic Acid)IBA 12/2017 - 01/2001
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2017 - 08/2013
3	InterleukinsIBA 01/2017 - 09/2001
3	Therapeutic UsesIBA 06/2016 - 09/2000
3	Immunoglobulin G (IgG)IBA 08/2015 - 06/2012
3	AcidsIBA 06/2009 - 09/2000
3	Monoclonal AntibodiesIBA 08/2005 - 05/2001
3	Interleukin-11 (Interleukin 11)IBA 11/2001 - 02/2000
3	Se-allylselenocysteineIBA 01/2001 - 11/2000
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2024 - 10/2017
2	Metformin (Glucophage)FDA LinkGeneric 11/2022 - 05/2022
2	Streptozocin (Streptozotocin)FDA Link 05/2022 - 01/2012
2	EnzymesIBA 01/2019 - 09/2014
2	Hyaluronic Acid (Hyaluronan)IBA 05/2018 - 11/2001
2	Bone Morphogenetic Protein 7IBA 09/2017 - 01/2016
2	Silicon Dioxide (Silica)FDA LinkGeneric 09/2017 - 01/2016
2	Matrix Metalloproteinases (MMPs)IBA 09/2017 - 11/2000
2	ProcalcitoninIBA 04/2017 - 06/2011
2	GhrelinIBA 01/2017 - 01/2014
2	Interleukin-17 (Interleukin 17)IBA 01/2017 - 10/2010
2	salicylhydroxamic acid (SHAM)IBA 12/2016 - 01/2014

Therapy/Procedure

10	Therapeutics 02/2024 - 05/2001
5	Transplantation 06/2016 - 10/2000
4	Drug Therapy (Chemotherapy) 08/2023 - 06/2006
4	Aftercare (After-Treatment) 08/2017 - 08/2012
3	Intraperitoneal Injections 05/2022 - 06/2009
3	Cord Blood Stem Cell Transplantation 11/2005 - 10/2000
3	Chemoprevention 01/2001 - 06/2000
2	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 12/2019
2	Gastrectomy 12/2019 - 01/2014
2	Immunotherapy 10/2017 - 04/2016